1. GBp

    4,470

    Today's change

    4.50 / +0.10%

    1 year change

    +8.93%

    As of Feb 27 2015 17:07 GMT. Data delayed by at least 15 minutes.

Search for AstraZeneca PLC and
  1. 10 hours ago

    AstraZeneca carves out antibiotic research

    AstraZeneca is to set up a standalone company to take over its research into new antibiotics for gonorrhoea and other...

  2. February 20, 2015

    Week in Review, February 21

    A round up of some of the week’s most significant corporate events and news stories. HSBC hit by Swiss raid HSBC suffered...

Special Reports

  1. 50 Top Business Ideas

    The FT puts the spotlight on which inventions and innovations have helped to create to...
  2. Combating Cancer

    A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
Search more Special Reports on this topic.

  1. February 19, 2015

    Centrica leads FTSE lower after profit fall

    Centrica was the biggest faller on the FTSE 100 on Thursday morning after the gas supplier reported a sharp fall in profit....

  2. February 17, 2015

    AstraZeneca lines up pharma critic for board

    AstraZeneca has nominated to its board a US scientist who has tweeted strongly critical views of the pharmaceuticals...

  3. February 17, 2015

    London stocks hit by Greece woes

    London stocks made a weaker start on Tuesday as talks between Greece and the European Union broke down, creating a damper on...

  4. February 16, 2015

    Compound sharing boosts drugs success

    In every science-based industry, the 20th-century model of research and development carried out in closed corporate labs is...

  5. February 16, 2015

    Gene editing comes of healthcare age

    Genetic engineering first became possible with the invention of “recombinant DNA” technology in the early 1970s. But for...

  6. February 10, 2015

    Healthcare: The race to cure rising drug costs

    Since contracting hepatitis C 25 years ago, Lucinda Porter’s biggest fear has been that she would infect someone else with...

  7. February 6, 2015

    Pharma takes a dose of sense from the deals doctor

    Taking the wrong combination of drugs can have serious side effects. The same goes for pharmaceuticals dealmaking. Mix up...

  8. February 5, 2015

    Pfizer: only in America

    M&A begins at home for Pfizer. It may not end there. Jilted by AstraZeneca in 2014 — it had hoped to “invert” into its...

  9. February 5, 2015

    AstraZeneca / Sanofi: inversion

    It looks upside down. Two big European pharma groups reported 2014 results on Thursday. AstraZeneca clocked in with a 3 per...

  10. February 5, 2015

    Pfizer’s $17bn Hospira buy could lead to break-up

    Is Pfizer going through a slow-motion break-up? The prevailing view among many analysts on Thursday was Yes, after it...

  11. February 5, 2015

    Lazard’s M&A advisory revenues top $1bn

    Lazard’s merger and acquisition advisory revenues topped $1bn for the first time in the US investment bank’s history in...

  12. February 5, 2015

    AstraZeneca to pay $600m for Actavis respiratory drugs

    AstraZeneca has agreed to pay $600m for the rights to Actavis’s branded respiratory drugs business in North America as it...

  13. February 2, 2015

    Big pharmaceuticals groups faces biosimilars challenge

    Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

  14. January 27, 2015

    Pfizer chief says big acquisition not required

    Pfizer on Tuesday touted its prospects as a standalone company and said it did not need to pursue a big deal, as it warned...

  15. January 19, 2015

    Peter Wallenberg, Swedish industrialist, 1926-2015

    Peter Wallenberg, the Swedish industrialist who has died aged 88, was long at the helm of one of Europe’s most powerful...

  16. January 14, 2015

    AstraZeneca receives fillip from drug data

    AstraZeneca’s hopes of meeting its ambitious growth targets received a fillip on Wednesday from data showing that its...

  17. January 7, 2015

    Pharma takeover battles boost FTSE 100 performance

    Two companies at the centre of takeover battles had the biggest positive impact on the performance of the FTSE 100 last...

  18. December 26, 2014

    Big pharma cashes in as M&A fever sweeps sector

    It was a big year for big pharma as a succession of multibillion-dollar mergers and acquisitions swept the industry. More...

  19. December 22, 2014

    Takeover volumes move to highest post-crisis levels

    Corporate takeover deals surged to their highest levels since the financial crisis this year, with merger and acquisition...

  20. December 8, 2014

    Old drugs put under the microscope

    Seven of the world’s biggest drugmakers will invite UK researchers to take a second look at experimental medicines that...

  21. December 5, 2014

    AstraZeneca wins ‘pay-for-delay’ ruling

    AstraZeneca has avoided a multibillion-dollar damages claim by winning a US court case about deals that seek to delay cheap...

  22. November 25, 2014

    AstraZeneca comes into focus as Pfizer’s cooling-off period ends

    It has been a popular pastime among healthcare investors and pharma executives for weeks: guessing the likelihood of Pfizer...

  23. November 18, 2014

    AstraZeneca fleshes out standalone strategy

    AstraZeneca championed its prospects as a standalone company on Tuesday as it gave more details of its strategy to investors...

  24. November 7, 2014

    UCB caps week of pharma dealmaking

    UCB of Belgium wrapped up another busy week of pharmaceuticals dealmaking on Friday with the $1.5bn disposal of its US...

  25. November 6, 2014

    AstraZeneca: priorities

    $4.20. This little number probably takes up quite a bit of space in the minds of executives at AstraZeneca. Azip, one of the...

  26. November 6, 2014

    AstraZeneca aims to ward off Pfizer by highlighting ‘tax inversion’ risks

    AstraZeneca sought to ward off Pfizer from making a fresh approach for the UK drugmaker by highlighting the increased risk...

  27. November 4, 2014

    Ackman gains ground in fight to force Allergan to sell to Valeant

    Bill Ackman chalked up a big victory in his battle to force Allergan, the maker of blockbuster wrinkle treatment Botox, to...

  28. November 4, 2014

    AstraZeneca strikes deals on cancer drugs

    AstraZeneca struck two deals on Tuesday aimed at strengthening its position in cancer drugs, as the UK pharmaceuticals group...

  29. October 28, 2014

    Pfizer chief: tax inversions still have ‘meaningful value’

    Pfizer has said there is still “meaningful value” to be found in tax inversions despite a White House crackdown that has...

  30. October 24, 2014

    Shire and AstraZeneca show standalone strength

    Britain’s number two and three drugmakers burnished their strength as independent companies on Friday when Shire reported...

  31. October 17, 2014

    Pfizer’s AstraZeneca pursuit knocked by Shire deal collapse

    The chances of Pfizer reviving its pursuit of AstraZeneca have been greatly diminished after the collapse of AbbVie’s £32bn...

  32. October 15, 2014

    Inversions should not (hop) scotch healthy trend for tax competition

    We come not to bury tax inversions but to praise them. The news that US drugs group AbbVie of the US may back out of its...

  33. October 13, 2014

    Renewed merger hopes boost AstraZeneca

    Refreshed hopes of another approach from Pfizer put AstraZeneca back in demand on Monday. AstraZeneca has slipped over the...

  34. October 12, 2014

    Fortune 500 companies spend more than $15bn on corporate responsibility

    US and UK companies in the Fortune Global 500 spend $15.2bn a year on corporate social responsibility (CSR) activities,...

  35. October 9, 2014

    Liverpool School of Tropical Medicine is in a global fight against suffering

    The war on neglected tropical diseases (NTDs) is being fought by “boots on the ground” in the jungles of Africa and Asia....

  36. October 6, 2014

    Gabriel Baertschi’s search for new AstraZeneca premises in Japan

    Just days after his arrival as the new president of AstraZeneca (AZ) in Japan in April 2013, Gabriel Baertschi could feel...

  37. October 5, 2014

    BD agrees to buy CareFusion for $12.2bn

    Becton Dickinson & Co, the medical technology and drug company, has agreed to acquire rival CareFusion for $12.2bn in a cash...

  38. September 30, 2014

    Multibillion cross-border deals make a return after five years

    It may have started in the US in the first few weeks of the year, but the global mergers and acquisitions boom of 2014 has...

Search for AstraZeneca PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca

  3. CEO Pascal Soriot on AstraZeneca's move to Cambridge...
    July 3, 2013

    CEO Pascal Soriot on AstraZeneca's move to Cambridge